Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yanmin Hu

Showing results (61-70 of 80) with videos related to

Pageof 8
Sort By:
The Journal of Antimicrobial Chemotherapy|December 16, 2017
Optimal doses of rifampicin in the standard drug regimen to shorten tuberculosis treatment duration and reduce relapse by eradicating persistent bacteriaYingjun Liu, Henry Pertinez, Fatima Ortega-Muro, et al.
Infection and Immunity|April 28, 2010
Comparison of the moonlighting actions of the two highly homologous chaperonin 60 proteins of Mycobacterium tuberculosisAna Cehovin, Anthony R M Coates, Yanmin Hu, et al.
ACS Applied Materials & Interfaces|October 24, 2019
Engineering the Atomic Layer of RuO<sub>2</sub> on PdO Nanosheets Boosts Oxygen Evolution CatalysisYanmin Hu, Xuan Luo, Geng Wu, et al.
Molecular Microbiology|November 13, 2009
3-Ketosteroid 9alpha-hydroxylase is an essential factor in the pathogenesis of Mycobacterium tuberculosisYanmin Hu, Robert van der Geize, Gurdyal S Besra, et al.
Clinical Pharmacology and Therapeutics|April 28, 2018
Forecasting Clinical Dose-Response From Preclinical Studies in Tuberculosis Research: Translational Predictions With RifampicinSebastian G Wicha, Oskar Clewe, Robin J Svensson, et al.
Infection and Immunity|January 30, 2008
A Mycobacterium tuberculosis mutant lacking the groEL homologue cpn60.1 is viable but fails to induce an inflammatory response in animal models of infectionYanmin Hu, Brian Henderson, Peter A Lund, et al.
Frontiers in Microbiology|January 8, 2015
Antimicrobial resistance characteristics and fitness of Gram-negative fecal bacteria from volunteers treated with minocycline or amoxicillinMiranda Kirchner, Muriel Mafura, Theresa Hunt, et al.
Nano Letters|April 16, 2024
Surface-Diffusion-Induced Amorphization of Pt Nanoparticles over Ru Oxide Boost Acidic Oxygen EvolutionYanmin Hu, Xiao Han, Shaojin Hu, et al.
Tuberculosis (Edinburgh, Scotland)|December 8, 2014
HspX knock-out in Mycobacterium tuberculosis leads to shorter antibiotic treatment and lower relapse rate in a mouse model--a potential novel therapeutic targetYanmin Hu, Alexander Liu, Maria C Menendez, et al.
Angewandte Chemie (International Ed. in English)|July 10, 2023
Cooperative Ni(Co)-Ru-P Sites Activate Dehydrogenation for Hydrazine Oxidation Assisting Self-powered H<sub>2</sub> ProductionYanmin Hu, Tingting Chao, Yapeng Li, et al.
Pageof 8

Showing results (61-70 of 80) with videos related to

Sort By:
Pageof 8
The Journal of Antimicrobial Chemotherapy|December 16, 2017
Optimal doses of rifampicin in the standard drug regimen to shorten tuberculosis treatment duration and reduce relapse by eradicating persistent bacteriaYingjun Liu, Henry Pertinez, Fatima Ortega-Muro, et al.
Infection and Immunity|April 28, 2010
Comparison of the moonlighting actions of the two highly homologous chaperonin 60 proteins of Mycobacterium tuberculosisAna Cehovin, Anthony R M Coates, Yanmin Hu, et al.
ACS Applied Materials & Interfaces|October 24, 2019
Engineering the Atomic Layer of RuO<sub>2</sub> on PdO Nanosheets Boosts Oxygen Evolution CatalysisYanmin Hu, Xuan Luo, Geng Wu, et al.
Molecular Microbiology|November 13, 2009
3-Ketosteroid 9alpha-hydroxylase is an essential factor in the pathogenesis of Mycobacterium tuberculosisYanmin Hu, Robert van der Geize, Gurdyal S Besra, et al.
Clinical Pharmacology and Therapeutics|April 28, 2018
Forecasting Clinical Dose-Response From Preclinical Studies in Tuberculosis Research: Translational Predictions With RifampicinSebastian G Wicha, Oskar Clewe, Robin J Svensson, et al.
Infection and Immunity|January 30, 2008
A Mycobacterium tuberculosis mutant lacking the groEL homologue cpn60.1 is viable but fails to induce an inflammatory response in animal models of infectionYanmin Hu, Brian Henderson, Peter A Lund, et al.
Frontiers in Microbiology|January 8, 2015
Antimicrobial resistance characteristics and fitness of Gram-negative fecal bacteria from volunteers treated with minocycline or amoxicillinMiranda Kirchner, Muriel Mafura, Theresa Hunt, et al.
Nano Letters|April 16, 2024
Surface-Diffusion-Induced Amorphization of Pt Nanoparticles over Ru Oxide Boost Acidic Oxygen EvolutionYanmin Hu, Xiao Han, Shaojin Hu, et al.
Tuberculosis (Edinburgh, Scotland)|December 8, 2014
HspX knock-out in Mycobacterium tuberculosis leads to shorter antibiotic treatment and lower relapse rate in a mouse model--a potential novel therapeutic targetYanmin Hu, Alexander Liu, Maria C Menendez, et al.
Angewandte Chemie (International Ed. in English)|July 10, 2023
Cooperative Ni(Co)-Ru-P Sites Activate Dehydrogenation for Hydrazine Oxidation Assisting Self-powered H<sub>2</sub> ProductionYanmin Hu, Tingting Chao, Yapeng Li, et al.
Pageof 8